Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 5, 2003, Pages 432-436

  Steffens, Marc ^a   Feuerstein, Thomas J ^a   Van Velthoven, Vera ^a   Schnierle, Peter ^b   Knörle, Rainer ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Inst Biochemische Analysen M   (Germany)

Author keywords

Anandamide; Cannabinoid receptor; Endocannabinoid release; HPLC; Human brain; Rat brain

Indexed keywords

ANANDAMIDE; POTASSIUM ION; SOLVENT;

AMYGDALOID NUCLEUS; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; BRAIN TISSUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPOLARIZATION; EXTRACTION; FLUOROMETRY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; ISOLATION PROCEDURE; MEASUREMENT; NEOCORTEX; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; SOLID; SOLVENT EXTRACTION; SPECIES COMPARISON; STIMULATION;

AMYGDALA; ANIMALS; ARACHIDONIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOCANNABINOIDS; HIPPOCAMPUS; HUMANS; MALE; NEOCORTEX; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; SPECIES SPECIFICITY; TIME FACTORS;

EID: 0344944863     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0817-1     Document Type: Article

References (25)

1. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-345
2. Arai Y, Fukushima T, Shirao M, Yang X, Imai K (2000) Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection. Biomed Chromatogr 14:118-124
3. Berry EM, Mechoulam R (2002) Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95:185-190
4. Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun 256:377-380
5. Devane WA, Hanus L, Breuer A, Pertwee, RG, Stevenson, LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
6. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691
7. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:231-235
8. Fride E, Mechoulam R (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231:313-314
9. Gessa GL, Mascia MS, Casu MA, Carta G (1997) Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR141716A. Eur J Pharmacol 327:R1-2
10. Gifford AN, Ashby Jr CR (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN55212-2, and is potentiated by the cannabinoid antagonist, SR141716A. J Pharmacol Exp Ther 277:1431-1436
11. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-363
12. Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73-81
13. Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernandez-Ruiz JJ, Hansen HS (2001) Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem 78:1415-1427
14. Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69:631-638
15. Jacobsson SO, Wallin T, Fowler CJ (2001) Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther 299:351-359
16. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518
17. Kempe K, Hsu FF, Bohrer A, Turk J (1996) Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J Biol Chem 271:17287-17295
18. Mallet PE, Beninger RJ (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9- tetrahydrocannabinol or anandamide. Psychopharmacology 140:11-19
19. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
20. Radin NS (1981) Extraction of tissue lipids with a solvent of low toxicity. Methods Enzymol 72:5-7
21. Saunders RD, Horrocks LA (1984) Simultaneous extraction and preparation for high-performance liquid chromatography of prostaglandins and phospholipids. Anal Biochem 143:71-75
22. Schlicker E, Kathmann M (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572
23. Steffens M, Szabo B, Klar M, Rominger A, Zentner J, Feuerstein TJ (2003) Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex. Neuroscience 120:455-465
24. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentation. Nature 388:773-777
25. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci 100:1393-1398